These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol. Messina JC; Offman E; Carothers JL; Mahmoud RA Clin Ther; 2019 Nov; 41(11):2343-2356. PubMed ID: 31732149 [TBL] [Abstract][Full Text] [Related]
3. Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients. Leach CL; Kuehl PJ; Chand R; McDonald JD J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):334-40. PubMed ID: 25671692 [TBL] [Abstract][Full Text] [Related]
4. An in vitro evaluation of importance of airway anatomy in sub-regional nasal and paranasal drug delivery with nebulizers using three different anatomical nasal airway replicas of 2-, 5- and 50-Year old human subjects. Hosseini S; Golshahi L Int J Pharm; 2019 May; 563():426-436. PubMed ID: 30974192 [TBL] [Abstract][Full Text] [Related]
5. Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray. Doughty DV; Hsu W; Dalby RN Drug Dev Ind Pharm; 2014 Jun; 40(6):711-8. PubMed ID: 23594299 [TBL] [Abstract][Full Text] [Related]
6. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation. Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701 [TBL] [Abstract][Full Text] [Related]
7. Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults. Alfaifi A; Hosseini S; Esmaeili AR; Walenga R; Babiskin A; Schuman T; Longest W; Hindle M; Golshahi L Int J Pharm; 2022 Jun; 622():121858. PubMed ID: 35643344 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Intranasal Vaccine Delivery Using Anatomical Replicas of Infant Nasal Airways. Wilkins JV; Golshahi L; Rahman N; Li L Pharm Res; 2021 Jan; 38(1):141-153. PubMed ID: 33449250 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler. Kappeler D; Sommerer K; Kietzig C; Huber B; Woodward J; Lomax M; Dalvi P Respir Med; 2018 May; 138():107-114. PubMed ID: 29724381 [TBL] [Abstract][Full Text] [Related]
11. Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. Shrewsbury SB; Armer TA; Newman SP; Pitcairn G Int J Pharm; 2008 May; 356(1-2):137-43. PubMed ID: 18289809 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica. Siu J; van Strien J; Campbell R; Roberts P; Tingle MD; Inthavong K; Douglas RG Pharm Res; 2022 Feb; 39(2):317-327. PubMed ID: 35137359 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model. Sawant N; Donovan MD Pharm Res; 2018 Mar; 35(5):108. PubMed ID: 29582159 [TBL] [Abstract][Full Text] [Related]
14. Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. Warnken ZN; Smyth HDC; Davis DA; Weitman S; Kuhn JG; Williams RO Mol Pharm; 2018 Apr; 15(4):1392-1402. PubMed ID: 29485888 [TBL] [Abstract][Full Text] [Related]
15. Importance of Spray-Wall Interaction and Post-Deposition Liquid Motion in the Transport and Delivery of Pharmaceutical Nasal Sprays. Kolanjiyil AV; Alfaifi A; Aladwani G; Golshahi L; Longest W Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631539 [TBL] [Abstract][Full Text] [Related]
16. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure. Inthavong K; Fung MC; Yang W; Tu J J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):59-67. PubMed ID: 24914675 [TBL] [Abstract][Full Text] [Related]
17. Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children. Laube BL; Sharpless G; Vikani AR; Harrand V; Zinreich SJ; Sedberry K; Knaus D; Barry J; Papania M J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):320-33. PubMed ID: 25679810 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate. Mehta R; Moore A; Riddell K; Joshi S; Chan R J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040 [TBL] [Abstract][Full Text] [Related]
19. Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery. Chen J; Martin AR; Finlay WH Curr Pharm Des; 2021; 27(12):1482-1497. PubMed ID: 33183191 [TBL] [Abstract][Full Text] [Related]
20. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity. Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418 [No Abstract] [Full Text] [Related] [Next] [New Search]